에이프릴바이오

397030 코스닥
67,900 1,300 (-1.88%)
기준 : 02/12 09:25
  • 시가총액
    16,153억
  • 주식수
    2,280만
  • PER
    -1840.53배
  • PBR
    17.87배
  • ROE
    -0.97%
  • 결산월
    12월

25.4Q 업데이트 - 잠정실적

  • 재무분석
  • 20년 재무제표
  • 손익계산서
자세히

손익계산서를 통해 매출액과 비용 그리고 이익(손실) 규모를 알 수 있습니다. 기업의 매출액에서 모든 비용을 제외하고 남는 돈을 순이익이라고 합니다. 순이익이 많을 수록 기업가치는 높아지게 됩니다.
손익계산서를 볼 때는 '많이 팔고 많이 남기는 회사'를 찾으면 됩니다. 경쟁 기업에 비해 매출액 규모가 크고, 순이익을 많이 남기면 경쟁우위에 있는 기업이라고 할 수 있습니다.

  • 데이터
  • 개별 재무제표
  • 국제회계
설정
연환산 연간 분기
세부항목 소수점
단위 : 억원
손익계산서 2025/12 2025/09 2025/06 2025/03 2024/12 2024/09 2024/06 2024/03 2023/12 2023/09 2023/06 2023/03 2022/12 2022/09 2022/06 2022/03 2021/12 2021/09 2021/06 2021/03 2020/12 2020/09 2020/06 2020/03 2019/12 2019/09
매출액(수익) N/AN/A 8989.7 8989.7 296296.8 275275.1
내수 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
수출 N/AN/A 2121.7 2121.7 2121.7 N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
매출원가 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
원재료 N/AN/A 33.7 33.7 66.2 44.1
재고자산의변동 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타원가 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
인건비 N/AN/A 2020.5 2727.9 3030.5 2727.4
감가상각비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A -24-24.2 -31-31.7 -36-36.7 -31-31.6
매출총이익 N/AN/A 8989.7 8989.7 296296.8 275275.1
판매비와관리비 N/AN/A 105105.8 105105.2 104104.0 106106.4
급여 N/AN/A 2020.7 2424.8 2323.3 2222.7
퇴직급여 N/AN/A 22.7 22.7 22.7 22.6
복리후생비 N/AN/A 22.6 22.4 22.1 22.1
임차료 N/AN/A 00.7 00.7 00.8 00.8
수도광열비 N/AN/A 00.3 00.3 00.3 00.3
전산처리비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지급수수료 N/AN/A 44.6 44.9 1212.6 1313.5
용역비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
수출비용 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
판매수수료 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
판매촉진비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
광고선전비 N/AN/A 00.0 N/AN/A N/AN/A N/AN/A
애프터서비스비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
운반비 N/AN/A 00.0 00.0 00.0 00.0
포장비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
연구개발비 N/AN/A 4949.3 3636.3 2929.0 3232.0
개발비상각 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
대손상각비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
감가상각비 N/AN/A 66.9 66.9 66.9 77.0
무형자산상각비 N/AN/A 00.0 00.0 00.0 00.0
기타 N/AN/A 1717.6 2525.8 2525.9 2525.0
영업이익 -72-72.6 -16-16.1 -15-15.4 192192.7 168168.6
EBITDA N/AN/A -29-29.3 -9-9.3 210210.5 188188.2
금융손익 N/AN/A 77.0 2525.0 3333.5 3131.4
금융수익 N/AN/A 7676.2 7575.5 6464.2 6262.1
이자수익 N/AN/A 3535.7 3636.2 3535.0 3333.1
외환거래이익 N/AN/A 2020.1 1818.9 2222.2 2222.1
외환차익 N/AN/A 33.2 33.2 33.2 33.1
외화환산이익 N/AN/A 1616.9 1515.6 1818.9 1919.0
기타 N/AN/A 33.2 33.2 33.2 33.1
배당금수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산평가이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
파생상품이익 N/AN/A 2020.3 2020.3 66.9 66.9
기타 N/AN/A 00.0 00.0 00.0 00.0
금융비용 N/AN/A 6969.2 5050.4 3030.6 3030.7
이자비용 N/AN/A 88.2 1010.4 1212.3 1414.2
외환거래손실 N/AN/A 55.7 2525.8 22.6 00.9
외환차손 N/AN/A 1313.9 77.8 22.1 00.9
외화환산손실 N/AN/A -8-8.1 1717.9 00.4 N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
대손상각비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산평가손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
파생상품손실 N/AN/A 5353.9 1313.0 1414.4 1414.4
기타 N/AN/A 11.2 11.2 11.2 11.2
기타영업외손익 N/AN/A 00.3 00.0 00.0 00.0
기타영업외수익 N/AN/A 00.3 00.0 00.0 00.0
이자수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환거래이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환차익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외화환산이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
수수료수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
배당금수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
임대료 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
로열티수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자부동산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
유형,리스자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
무형자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
파생상품이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
자산손상차손환입 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
대손충당금환입 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자자산평가이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
채무면제이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A 00.3 00.0 00.0 00.0
기타영업외비용 N/AN/A 00.0 00.0 00.1 00.0
이자비용 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환거래손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외화환산손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타대손상각비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기부금 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자부동산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
유형,리스자산처분손실 N/AN/A N/AN/A N/AN/A 00.0 00.0
무형자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
파생상품손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
자산손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
자산평가손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
사채상환손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A 00.0 00.0 00.1 00.0
종속기업및관계기업관련손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법적용투자주식손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업처분손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업관련손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
법인세비용차감전계속사업이익 N/AN/A -8-8.7 99.5 226226.2 200200.0
법인세비용 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
중단사업이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
당기순이익 -97-97.2 -8-8.7 99.5 226226.2 200200.0
*지배지분 연결순이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타포괄이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산평가손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
매도가능금융자산평가손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업등기타포괄이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
해외사업환산손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
현금흐름위험회피적립금 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
재평가손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타포괄이익관련법인세 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
총포괄이익 N/AN/A -8-8.7 99.5 226226.2 200200.0
지배지분 총포괄이익 N/AN/A -8-8.7 99.5 226226.2 200200.0
비지배지분 총포괄이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
주당순이익 N/AN/A -37-37.0 3939.9 1,0321,032.9 912912.5
시가총액 N/AN/A 6,9736,973.0 3,7263,726.0 3,0623,062.6 3,6343,634.5
주가 N/AN/A 30,90030,900.0 16,54016,540.0 13,62013,620.0 16,20016,200.0
주가수익배수 N/AN/A -794.53-794.53 388.35388.35 13.5313.53 18.1718.17
주식수(만주) N/A 2,280 2,253 2,249 2,244 2,192 2,175 N/A N/A N/A 2,138 N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A

20년 재무제표를 한번에! 프리미엄 서비스를 무제한으로 이용하세요. 프리미엄 55% 평생할인

밸류라인 서비스를 무제한 이용하세요 프리미엄